本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Arcutis Biotherapeutics Inc.

24.95
+1.446.10%
成交量:177.93萬
成交額:4,426.28萬
市值:31.20億
市盈率:115.80
高:25.62
開:23.63
低:23.63
收:23.51
52周最高:31.77
52周最低:16.57
股本:1.25億
流通股本:1.11億
量比:2.51
換手率:1.60%
股息:- -
股息率:- -
每股收益(TTM):0.2154
每股收益(LYR):-0.1269
淨資產收益率:15.86%
總資產收益率:5.09%
市淨率:14.14
市盈率(LYR):-196.63

資料載入中...

2025/03/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/03/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/03/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/25

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/02/25

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/25

重要事件披露

Form 8-K - Current report
2025/02/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/13

重要事件披露

Form 8-K - Current report
2025/01/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/31

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]